Indian Carboplatin Exporters: Complete Supplier Ranking with Market Share — 829 Manufacturers (2026) — TransData Nexus

Q: Who is the largest carboplatin buyer importing from India?

FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) is the largest carboplatin importer from India with a 22.4% market share and import value of $15.9M.

Q: How many carboplatin buyers import from India?

There are 829 active carboplatin buyers importing from India, with a combined import market of $70.9M across 3,637 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top carboplatin buyers from India?

The top 5 carboplatin buyers — FRESENIUS KABI DEUTSCHLAND GMBH, EUGIA US LLC, EUGIA US LLC,, CHRIS LESSLY, CPC "BIOCON" LLC — together control 38.2% of total carboplatin import value from India.

Suresh Sormare

Carboplatin

India Pharmaceutical Trade Intelligence

$70.9M273 Suppliers138 CountriesHS 30049047

ExportsIndia → GERMANY22.6%India → UNITED STATES17.1%

ImportsAUSTRALIA → India$1.1M SOUTH KOREA → India$89.3K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Market Analysis: Top Importing Countries & Their Importers

1Germany

Germany emerges as the first largest importing country, achieving a total trade value of $16.0M through 391 shipments. This represents a market share of 22.6% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Germany has a diverse importer base, with their top importers including:

• FRESENIUS KABI DEUTSCHLAND GMBH - $15.9M (99.3% of country's total business)

Key Insight: Germany demonstrates strong market positioning with an average shipment value of $40.9K, indicating premium pricing strategy compared to the market average of $19.5K.

Germany is a key market for Carboplatin imports, representing 22.6% of total trade value.

Primary Market

Secondary Market

2United States

United States emerges as the second largest importing country, achieving a total trade value of $12.2M through 65 shipments. This represents a market share of 17.1% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Carboplatin buyer market intelligence

1Buyer Segment Analysis

The buyer landscape for Carboplatin imported from India encompasses several key segments:

1. Distributors: Entities that purchase Carboplatin in bulk to supply to healthcare providers. For instance, FRESENIUS KABI DEUTSCHLAND GMBH in Germany, accounting for $15.90 million in imports, likely operates as a distributor, supplying hospitals and clinics. Distributors typically place large, periodic orders to maintain a steady supply chain.

2. Hospital Groups: Healthcare institutions procuring directly for patient treatment. While specific hospital groups are not identified in the top buyers, entities like FRESENIUS KABI COLOMBIA SAS ($1.08 million) may serve hospital networks. Their purchasing patterns are driven by patient demand and treatment protocols, often resulting in consistent, scheduled orders.

3. Retail Chains: Pharmacy chains that stock Carboplatin for outpatient prescriptions. THE ESSES PHARMACY (PVT) LTD in Sri Lanka, with imports totaling $1.06 million, exemplifies this segment. Retail chains order based on prescription trends, leading to variable order sizes and frequencies.

4. Government Procurement: National health agencies and international organizations like UNICEF and the Global Fund procure Carboplatin for public health initiatives. While not explicitly listed among the top buyers, such entities engage in tender-based purchasing, often resulting in large, infrequent orders aligned with budget cycles and program needs.

5. Re-exporters: Companies that import Carboplatin for the purpose of exporting to other markets. For example, ACCORD FARMA S A DE C V in Mexico, with imports of $0.90 million, may distribute to neighboring countries. Re-exporters' purchasing patterns depend on regional demand and trade agreements, leading to variable order sizes.

Country-Specific Import Regulations

TransData Nexus Carboplatin buyer market intelligence

1Country-Specific Import Regulations

Germany

1. Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

2. Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.

3. Estimated Timeline: Approximately 7 to 12 months.

4. Import Tariff/Duty: Medicinal products under HS Code 30049047 are typically exempt from import duties within the EU.

United States

1. Regulatory Authority: Food and Drug Administration (FDA).

2. Import Registration Process: Requires FDA approval through a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), including compliance with Current Good Manufacturing Practices (CGMP).

3. Estimated Timeline: ANDA approvals average 10 months; NDAs may take longer.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049047 are generally duty-free.

Thailand

1. Regulatory Authority: Thai Food and Drug Administration (Thai FDA).

2. Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data.

3. Estimated Timeline: Approximately 12 to 18 months.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are subject to a 5% import duty.

Philippines

1. Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).

2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving evaluation of quality, safety, and efficacy data.

3. Estimated Timeline: Approximately 6 to 12 months.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are generally exempt from import duties.

Demand Drivers & Market Opportunity

TransData Nexus Carboplatin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Carboplatin is primarily driven by the prevalence of cancers such as ovarian, lung, and testicular cancers, for which Carboplatin is a standard chemotherapy agent. According to the World Health Organization (WHO), cancer remains a leading cause of morbidity and mortality worldwide, with approximately 19.3 million new cases and 10 million cancer-related deaths in 2020. This high disease burden necessitates substantial procurement of effective chemotherapeutic agents like Carboplatin.

Government healthcare programs and the expansion of universal health coverage in various countries have also bolstered the demand for essential medicines. Carboplatin's inclusion in the WHO Essential Medicines List underscores its critical role in cancer treatment, prompting national health systems to prioritize its availability. Tender-based purchasing mechanisms are commonly employed by governments and international organizations to procure such essential medicines, ensuring cost-effectiveness and consistent supply. The presence of 829 buyers across 138 countries, as per TransData Nexus data, reflects a broad and sustained global demand for Carboplatin, presenting significant market opportunities for suppliers.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Carboplatin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest carboplatin buyer importing from India?

Based on import volume and value, FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) leads with $15.9M in imports and a 22.4% market share — the highest of any single carboplatin importer. EUGIA US LLC (UNITED STATES) and EUGIA US LLC, (UNITED STATES) are the next largest buyers.

QHow many companies buy carboplatin from India?

There are 829 active carboplatin buyers importing from India, with a combined market of $70.9M across 3,637 shipments to 138 countries. The top 5 buyers hold 38.2% of total import value, while the remaining 824 buyers handle the other 61.8%.

QWhich countries import the most carboplatin from India?

The top importing countries for carboplatin from India are Germany (22.6%), United States (17.1%), Thailand (6.8%), Philippines (4.6%), Ukraine (4.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of carboplatin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for carboplatin from India?

The average import transaction value for carboplatin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Carboplatin buyer market intelligence

1Buyer Segment Analysis

The buyer landscape for Carboplatin imported from India encompasses several key segments:

Country-Specific Import Regulations

TransData Nexus Carboplatin buyer market intelligence

1Country-Specific Import Regulations

Germany

1. Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

2. Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.

3. Estimated Timeline: Approximately 7 to 12 months.

4. Import Tariff/Duty: Medicinal products under HS Code 30049047 are typically exempt from import duties within the EU.

United States

1. Regulatory Authority: Food and Drug Administration (FDA).

3. Estimated Timeline: ANDA approvals average 10 months; NDAs may take longer.

4. Import Tariff/Duty: Pharmaceutical products under HS Code 30049047 are generally duty-free.

Thailand

1. Regulatory Authority: Thai Food and Drug Administration (Thai FDA).

2. Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data.

3. Estimated Timeline: Approximately 12 to 18 months.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are subject to a 5% import duty.

Philippines

1. Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).

2. Import Registration Process: Requires a Certificate of Product Registration (CPR), involving evaluation of quality, safety, and efficacy data.

3. Estimated Timeline: Approximately 6 to 12 months.

4. Import Tariff/Duty: Pharmaceuticals under HS Code 30049047 are generally exempt from import duties.

Demand Drivers & Market Opportunity

TransData Nexus Carboplatin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Carboplatin

Carboplatin

Who Buys Carboplatin from India — 829 Importers Behind a $70.9M Market

Top Carboplatin Importers — Ranked by Import Value

Top Carboplatin Buyers & Importers

Related Analysis

Need Details?

Carboplatin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Carboplatin — and from which countries?

Carboplatin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Germany

2United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Carboplatin Buyers & Importers

QWho is the largest carboplatin buyer importing from India?

QHow many companies buy carboplatin from India?

QWhich countries import the most carboplatin from India?

QWhat is the average import order value for carboplatin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Thailand

4Philippines

5Ukraine

Analysis Methodology